HCPCS Codes Similar to M1413

HCPCS Codes Similar to “M1413” Code.
Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy

M1414 Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication) Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	M1415 Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON
M1411 Currently on first-line immune checkpoint inhibitors without chemotherapy Code added date: 20250101 Code effective date: 20250101 TXT \| PDF \| XML \| JSON	L1 Provider attestation that the hospital laboratory test(s) is not packaged under the hospital opps Code added date: 20140701 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
M1180 Patients on immune checkpoint inhibitor therapy Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	M1183 Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
M1185 Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON	M1194 Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing) Code added date: 20230101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON
G9162 Spoken language expression functional limitation, current status at therapy episode outset and at reporting intervals Code added date: 20130101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON	G9163 Spoken language expression functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting Code added date: 20130101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON
G9164 Spoken language expression functional limitation, discharge status at discharge from therapy or to end reporting Code added date: 20130101 Code effective date: 20200101 TXT \| PDF \| XML \| JSON	G9313 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis for documented reason Code added date: 20140101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
G9314 Amoxicillin, with or without clavulanate, not prescribed as first line antibiotic at the time of diagnosis, reason not given Code added date: 20140101 Code effective date: 20140101 TXT \| PDF \| XML \| JSON	G9315 Amoxicillin, with or without clavulanate, prescribed as a first line antibiotic at the time of diagnosis Code added date: 20140101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON